• US FDA approves Lampit for the treatment of Chagas disease in children pharmaceutical-business-review
    August 12, 2020
    Bayer announced that the United States Food and Drug Administration (FDA) has approved Lampit (nifurtimox) for use in pediatric patients (from birth to less than 18 years of age and weighing at least 2.5 kg) for the treatment of Chagas disease ...
PharmaSources Customer Service